Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...

Manisha Koirala was diagnosed with stage IV ovarian cancer in 2012. She later made a recovery after undergoing treatment in ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...

In this video, Ursula A. Matulonis, MD, discusses new data on rinatabart sesutecan, or Rina-S, for patients with advanced ovarian cancer, which were presented at Society of Gynecologic Oncology Annual ...

In this video, Ursula A. Matulonis, MD, shares that although data from the REFRaME-O1 trial of luveltamab tazevibulin were presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer ...

The seventh warning indicator of poor ovary health or ovarian cancer is a visible change in the bowel movement. Studies have ...